Palbonix 125mg capsules (palbociclib) 21s

Palbonix 125 mg Capsules contains palbociclib, a targeted anti-cancer medication used in the treatment of hormone receptor-positive (HR+), HER2-negative breast cancer. It belongs to a class of drugs known as CDK4/6 inhibitors, which help slow down cancer cell division.

What is Palbonix 125 mg Capsule?

Palbonix (palbociclib) is an oral medication typically used in combination with hormonal therapies such as aromatase inhibitors or fulvestrant. It is commonly prescribed for advanced or metastatic breast cancer.

Uses of Palbonix 125 mg Capsules

• Treatment of HR-positive, HER2-negative breast cancer
• Management of advanced or metastatic breast cancer
• Used in combination with letrozole or fulvestrant
• Helps control disease progression in postmenopausal women

Benefits of Palbonix 125 mg

• Targets cancer cells with precision (CDK4/6 inhibition)
• Slows tumor growth and spread
• Improves progression-free survival
• Enhances effectiveness of hormone therapy
• Convenient oral capsule regimen

How Palbonix Works

Palbonix (palbociclib) blocks cyclin-dependent kinases 4 and 6 (CDK4/6), proteins that are essential for cell division. By inhibiting these enzymes, it prevents cancer cells from multiplying.

Side Effects of Palbonix 125 mg Capsules

Common Side Effects

• Low white blood cell count (neutropenia)
• Fatigue
• Nausea
• Hair thinning
• Mouth sores

Serious Side Effects

• Severe infections due to low immunity
• Lung inflammation (interstitial lung disease, rare)
• Blood clots
• Liver abnormalities

Precautions & Warnings

• Regular blood count monitoring is essential
• Avoid during pregnancy and breastfeeding
• Use effective contraception during treatment
• Inform doctor about any signs of infection (fever, chills)

Dosage & Administration

• Typically taken once daily for 21 days, followed by 7 days off (28-day cycle)
• Take with food at the same time each day
• Follow doctor’s instructions strictly

Packaging Information

• Pack size: 21 capsules
• Designed for one treatment cycle

Conclusion

Palbonix 125 mg Capsules (21’s) is an advanced targeted therapy for HR-positive, HER2-negative breast cancer. When combined with hormone therapy, it significantly improves treatment outcomes and helps control disease progression.